Abstract

Cardiovascular diseases are the main source of death and morbidity in developed and developing nations. Animal models are required to propel our understanding of the pathogenesis, increase our knowledge, disease progress, and mechanism behind cardiovascular disorder, providing new approaches focused to improve the diagnostic and the treatment of these pathological conditions and additionally to test various therapeutic ways to deal with tissue regeneration and re-establish heart working following damage. A perfect model framework ought to be reasonable, effectively controlled, reproducible, and physiologically illustrative of human disease, show cardinal signs and pathology that resembles after the human ailment and ethically stable. The decision of selection of animal model should be considered precisely since it influences exploratory results and whether results of the research can be sensibly matched with the human. In this way, no specific technique splendidly reproduces the human disease, and relying upon the model, extra cost burden, resources, infrastructure and the necessity for technical hands, should also be kept under consideration. Here we have discussed and compiled various methods of inducing myocardial infarction in animals, basically by surgery, chemicals and through genetic modification, this may benefit the researchers in getting a complied data regarding various methods through which they can induce myocardial infarction in animals.

Highlights

  • Cardiovascular diseases are the most common and leading cause of morbidity and mortality across the world

  • Anthracyclines, for example, doxorubicin and epirubicin are known for their cardiotoxic adverse effect and extensive research is done to investigate the component of anthracycline mediated cardiotoxicity

  • In view of the epidemiological and financial status of patient CHD-related HF a great determination to fight against this disorder are required

Read more

Summary

Introduction

Cardiovascular diseases are the most common and leading cause of morbidity and mortality across the world. CVD is a broad term which includes hypertension, coronary heart disease, congestive heart failure, and stroke. CVDs account 17.3 million deaths per annum globally (Reeve et al, 2005). Among all CVDs, Myocardial infarction (MI) is responsible for 10% of the total mortality (Alexander, Bruneau, 2010). In order to prevent and treat CHF more effectively, it is quite necessary to understand the pathophysiological mechanisms behind this disorder. In vivo models closely related to the structural and functional characteristics of human CHF are used for analysis. To study all aspects of CHF a single model can’t be used as every animal model has some pros and cons. When an animal model is being established To study all aspects of CHF a single model can’t be used as every animal model has some pros and cons. when an animal model is being established

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call